Business Responsibility and Sustainability Report (BRSR) and ESG Databook of Sai Life Sciences Limited for the FY 2025-26

25th August 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: SAILIFE BSE Scrip code: 544306 Dear Sir/Madam, Sub: Business Responsibility and Sustainability Report for the FY 2025-26. Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Business Responsibility and Sustainability Report (BRSR) and ESG Databook of the Company for the financial year 2025-26, which forms part of the Integrated Annual Report for the financial year 2025-26. The BRSR and ESG Databook is also uploaded on the Company’s website and can be accessed at: https://sailife.com/annual-reports/ Kindly take the above information on your record. Thanking you. Yours sincerely, For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No. A13721 Encl.: As above Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Business Responsibility and Sustainability Report & ESG Databook 2025-26 01-86 Statutory Reports Business Responsibility and Sustainability Report SECTION A: General Disclosures I. Details of listed entity 1. Corporate Identity Number (CIN) of the Company L24110TG1999PLC030970 2. Name of the Company Sai Life Sciences Limited 3. Year of Incorporation 1999 4. Registered Office Address Plot No.DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Medchal – Malkajgiri District, Hyderabad 500078, Telangana, India 5. Corporate Address # L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Miyapur Road, Gachibowli, Hyderabad – 500032, Telangana, India. 6. Email Address Investors@sailife.com 7. Telephone 040-68156000 8. Website www.sailife.com 9. Financial Year Reported 2025-2026 10. Name of the Stock Exchanges where shares are listed BSE Limited National Stock Exchange of India Limited 11. Paid-up Capital H 21,17,79,234 12. Name and contact details (telephone, email address) of the person Name: Runa Karan who may be contacted in case of any queries on the BRSR report Email: runa.k@sailife.com Phone: 040-68156107 13. Reporting boundary - Are the disclosures under this report made The disclosure under this report is made on a standalone basis, on a standalone basis (i.e. only for the entity) or on a consolidated covering all entities forming part of our standalone financial basis (i.e. for the entity and all the entities which form a part of its statements. consolidated financial statements, taken together). 14. Name of assurance provider TUV India Private Limited 15. Type of assurance obtained Reasonable Assurance for BRSR Core Indicators II. Products/Services 16. Details of business activities (accounting for 90% of the turnover) S. % of turnover of Description of Main Activity Description of Business Activity No. the Company 1 Contract Research, Integrated services spanning discovery, development and commercial 100% Development and manufacturing of pharmaceutical products Manufacturing 17. Products/Services sold by the Company (accounting for 90% of the turnover) S. % of total turnover Product/Service NIC Code No. contributed 1 Contract Research, Development and Manufacturing NIC Code : 72 (Scientific Research 100% and Development) III. Operations 18. Number of locations where plants and/or operations/offices of the Company are situated: Location Number of plants Number of offices Total National 4 1 5 International 1 2 3 Sai Life Sciences Limited Integrated Report FY 2025-26 19. Markets served by the Company a. Number of locations Locations Number National (No. of States) 5 International (No. of Countries) 16 b. What is the contribution of exports as a percentage of the total turnover of the Company? 96.84% c. Types of customers Sai Life Sciences Limited is a rapidly growing CRO and CRDMO serving global pharmaceutical and biotechnology companies. The company provides integrated discovery, development and manufacturing services for small molecules to clients. IV. Employees 20. Details as at the end of the Financial Year a. Employees and workers (including differently abled): S. Male Female Particulars Total (A) No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 3,806 3,238 85.08% 568 14.92% 2. Other than Permanent (E) 103 79 76.70% 24 23.30% 3. Total employees (D + E) 3,909 3,317 84.86% 592 15.14% WORKERS 4. Permanent (F) 0 0 0 0 0 5. Other than Permanent (G) 1,315 1,235 93.92% 80 6.08% 6. Total workers (F + G) 1,315 1,235 93.92% 80 6.08% b. Differently abled Employees and workers: S. Male Female Particulars Total (A) No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 3 3 100% 0 0 2. Other than Permanent (E) 0 0 0 0 0 3. Total employees (D + E) 3 3 100% 0 0 WORKERS 4. Permanent (F) 0 0 0 0 0 5. Other than Permanent (G) 0 0 0 0 0 6. Total workers (F + G) 0 0 0 0 0 21. Participation/Inclusion/Representation of Women No. and percentage of Females Total (A) No. (B) % (B/A) Board of Directors 6 1 17% Key Management Personnel 6 1 17% 22. Turnover rate for permanent employees and workers (disclose trends for the past 3 years) FY 2025-26 FY 2024-25 FY 2023-24 Male Female Total Male Female Total Male Female Total Permanent Employees 19.37 30.5 20.98 22.45 34.64 24.17 30.1 18.4 23.2 Permanent Workers NA NA NA 01-86 Statutory Reports V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. Name of holding/subsidiary/associate companies/joint ventures Does the entity indicated at Indicate whether Holding/ % of shares S. Name of the holding/ subsidiary/associate column A, participate in the Subsidiary/Associate/Joint held by the No. companies/joint ventures (A) Business Responsibility initiatives Venture Company of the Company (Yes/No) 1 Sai Life Sciences Inc Subsidiary 100 Yes 2 Sai Life Sciences Gmbh Subsidiary 100 Yes 3 Sai Life Pharma Private Limited Subsidiary 100 Yes VI. CSR Details* 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes (ii) Turnover: H 2,153 Cr (iii) Net worth: H 2,508 Cr *Values are based on standalone financials. VII. Transparency and Disclosure Compliances 25. Complaints/Grievances on any of the principles (Principle 1 to 9) under the National Guidelines on Responsible Business Conduct: FY 2025-26 FY 2024-25 Grievance Redressal Stakeholder Mechanism in place (Yes/ No. of No. of complaints No. of No. of complaints group from whom No) (If yes, then provide web complaints pending complaints pending compliant* is Remarks Remarks link for grievance redressal filed during resolution at filed during resolution at received policy) * the year close of the year the year close of the year Communities Yes 0 0 Nil 0 0 Nil Investors (other Yes 0 0 0 0 than shareholders) Shareholders As per applicable law 1 0 12 1 Employees and Yes 0 0 0 0 workers Customers** Yes 12 11 5 5 Value Chain Yes 0 0 0 0 Partners Others Yes 0 0 0 0 *Shareholders can register their grievances on the SCORES Portal at https://scores.sebi.gov.in/and the ODR Portal at https://smartodr.in/. All other stakeholder groups including customers, value chain partners, communities and employees and workers can raise a concern by accessing the Code of Conduct and Business Ethics on the website. They may also write and drop their grievance in the Complaint box installed at all the work locations. Several policies guiding the Company’s conduct with all its stakeholders, including grievance mechanisms are placed on the Company’s website and can be found on https://sailife.com/corporate-governance/. In addition, there are interna [Showing first 8,000 characters — download PDF for full document]